Imetelstat
Geron Corporation
['mds']
geron announces asco presentation reporting durable continuous transfusion independence with imetelstat in imerge phase 3 lower risk mds patients - health stocks hub $gern 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2